New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 12, 2014
07:56 EDTTAP, SBMRY, ABVMolson Coors could benefit from a AmBev, SABMiller combination, says ISI Group
ISI Group beileves Molson Coors (TAP) could play a role in a potential AmBev (ABV) acquisition of SABMiller (SBMRY). The analyst said Molson Coors would likely acquire SAB's 58% stake in the MillerCoors joint venture at an attractive, very accretive price, providing AmBev a solution to U.S. anti-trust issues. The firm expects Molson Coors' June 25 Investor Day to have a large crowd given the increased interest and speculation but expects management to focus on brand momentum, innovation and business model progress. Shares of Molson Coors are Buy rated with a $75 price target.
News For TAP;SBMRY;ABV From The Last 14 Days
Check below for free stories on TAP;SBMRY;ABV the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 18, 2014
13:03 EDTTAPMolson Coors, Heineken expand marketing partnership in Canada
Molson Coors and Heineken announced that they have expanded their marketing partnership in Canada, whereby Molson Coors Canada will assume responsibility for distributing five additional Heineken brands in Canada. The new, multi-year agreement further strengthens the existing Molson Coors and Heineken relationship. In addition to Heineken, Murphy’s, Newcastle and Strongbow, Molson Coors Canada will assume the rights to market and sell Dos Equis, Sol, Tecate, Birra Moretti and Desperados. Beginning on January 1, 2015, Molson Coors Canada will have the rights to market and distribute these brands on behalf of Heineken. As part of the new agreement, Molson Coors has also agreed to extend the existing partnership with Heineken to distribute Coors Light in Ireland.
August 14, 2014
10:05 EDTTAPOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:44 EDTTAPMolson Coors initiated with an Outperform at Credit Suisse
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use